ꢁꢀꢀꢀ
ꢂ7
E.S. Ramadan et al.: Synthesis of some 2-sulfanyl benzo[d]thiazolesꢂ
bath for 7 h, then cooled to 20°C, treated with ice-cold to contain 2.5ꢀ×ꢀ106 viable cells per mL. EAC cells, RPMI
water (50 mL), and basified with aqueous K2CO3 to pH 9. 1640 medium (Sigma Chemical Co.), and the tested com-
The product was collected by filtration and recrystallized pounds in DMSO were added in sterile test tubes. The
from EtOH as colorless crystals. Yield: 80% (0.16 g), Rfꢀ=ꢀ0.76 cells were incubated for 1 and 24 h at 37°C under a con-
(EtAc/MeOH, 1:1), m.p. 136–138°C. IR (KBr): νꢀ=ꢀ1635.03 stant overlay of 5% CO2. EAC viable cells were counted
1
(C=C, C=N) cm−1. H NMR (600 MHz, [D6]DMSO): δꢀ=ꢀ4.90 by trypan blue exclusion using a hemocytometer as
(s, 2 H, CH2–Cl), 7.29–8.31 (m, 14 H, Ar-Hꢀ+ꢀpyrazole-H). mentioned above. The fraction of surviving cells was
13C NMR (150 MHz, [D6]DMSO): δꢀ=ꢀ27.48 (CH2–Cl), 110.27, calculated as T/C, where T and C represent the number
134.85, 121.30–131.60, 138.78–140.25, 144.67, 147.76, 148.90, of viable cells in unit volume and the number of total
152.37, 164.85 (Ar-C). C25H16ClN5S2 (486.01): calcd. C 61.78, (viable dead) cells in the same unit volume, respectively.
H 3.32, N 14.41; found C 61.95, H 3.64, N 14.52.
4.11.2 Method B
5 Supporting information
A solution of compound 1a (0.17 g, 1.02 mmol) in dry DMF Copies of 1H NMR and 13C NMR spectra of the synthesized
(3.0 mL) was treated with NaH (0.05 g, 2.1 mmol) and compounds are given as Supporting Information available
heated under reflux for 1 h. Then, a solution of compound online (https://doi.org/10.1515/znb-2018-0078).
16 (0.18 g, 0.51 mmol) in absolute EtOH (25 mL) was added.
The reaction mixture was heated under reflux for an addi-
tional 7 h. The product that separated out on cooling was
filtered and recrystallized from EtOH to give colorless crys-
References
1
tals. Yield: 84% (0.21 g), m.p. 134–136°C. IR, H NMR and
13C NMR spectra were found to be superimposable with
[1] M. H. S. Gradwell, W. J. McGill, J. Appl. Polym. Sci. 1995, 58,
2193.
those of the product from method A.
[2] M. Finsgar, D. K. Merl, Corros. Sci. 2014, 83, 164.
[3] J. Li, C. W. Du, Z. Y. Liu, X. G. Li, M. Liu, Int. J. Electrochem. Sci.
2016, 11, 10690.
4.12 Antitumor testing
[4] A. C. Balaskas, M. Curioni, G. E. Thompson, Surf. Interface
Anal. 2015, 47, 1029.
[5] A. O. Gezerman, B. D. Çorbacioglu, J. Chem. 2015, 2015, 1.
Ehrlich cells were derived from the ascetic fluid from dis-
[6] K. Ramadas, N. Janarthanan, Synth. Commun. 1999, 29, 1003.
eased mouse purchased from the National Cancer Insti-
[7] L. Muthusubramanian, V. S. S. Rao, R. B. Mitra, J. Cleaner Prod.
tute (NCI), Cairo, Egypt. These cells were maintained by
2001, 9, 65.
weekly intraperitoneal transplantation of 2.5ꢀ×ꢀ106 cells in
[8] X. Fei, Y. Gu, Y. Ban, Z. Liu, B. Zhang, Bioorg. Med. Chem. 2009,
female Swiss albino mice. The tumor is characterized by
a moderately rapid growth, which leads to the death of
the mice in about 20 days due to distal metastasis. EAC
is of mammary origin, as spontaneous breast cancer
served as the original tumor from which the ascites
variant was obtained [34]. Ascetic fluid was withdrawn
under aseptic conditions (ultraviolet laminar flow
system) from the peritoneal cavity of tumor-bearing
mice by needle aspiration after 7 days of EAC cells ino-
culation. To adjust the number of EAC cells, tumor cells
obtained were diluted several times with normal saline.
EAC viable cells were counted by the trypan blue exclu-
sion method [35], where 10 μL trypan blue (0.05%) was
mixed with 10 μL of the cell suspension. Within 5 min,
the mixture was spread onto hemocytometer, covered
with a cover slip, and then the cells were examined
under a microscope. Dead cells were blue-stained but
viable cells were not. The cell suspension was adjusted
17, 585.
[9] N. Haroune, B. Combourieu, P. Besse, M. Sancelme, A.
Kloepfer, T. Reemtsma, H. De Wever, A. Delort, Appl. Environ.
Microbiol. 2004, 70, 6315.
[10] M. A. Azam, B. Suresh, Sci. Pharm. 2012, 80, 789.
[11] F. Wua, W. M. Hussein, B. P. Ross, R. P. McGeary, Curr. Org.
Chem. 2012, 16, 1555.
[12] C. Franchini, M. Muraglia, F. Corbo, M. A. Florio, A. D. Mola,
A. Rosato, R. Matucci, M. Nesi, F. van Bambeke, C. Vitali, Arch.
Pharm. Chem. Life Sci. 2009, 342, 605.
[13] M. V. De Almeida, S. H. Cardoso, J. V. De Assis, M. V. N. De
Souza, J. Sulfur Chem. 2007, 28, 17.
[14] P. Saxena, D. C. P. Singh, A. Ali, V. Sharma, Int. J. Pharm.
Pharm. Sci. 2013, 5, 454.
[15] S. Shafi, M. M. Alam, N. Mulakayala, C. Mulakayala, G. Vanaja,
A. M. Kalle, R. Pallu, M. S. Alam, Eur. J. Med. Chem. 2012, 49,
324.
[16] J. Koci, V. Klimesova, K. Waisser, J. Kaustova, H. Dahse, U.
Mollmann, Bioorg. Med. Chem. Lett. 2002, 12, 3275.
[17] S. P. Singh, R. S. Misra, S. S. Parmar, S. J. Brumleve, J. Pharm.
Sci. 1975, 64, 1245.
Brought to you by | University of Sussex Library
Authenticated
Download Date | 8/3/18 10:56 AM